Skip to main content
. 2023 Nov 29;16:86. doi: 10.1186/s12245-023-00566-1

Table 3.

Drugs and self-discharge from the emergency department during acute recreational drug toxicity

Total
n (%)
Self-discharge
n (%)
Crude OR 95% CI P value Adjusted OR 95% CI P value
Heroin 3615 (23.9) 599 (16.6) 1.70 1.53–1.89 < 0.001 1.44 1.26–1.64 < 0.001
Synthetic cannabinoids 440 (2.9) 73 (16.6) 1.49 1.15–1.92 0.002 1.44 1.10–1.89 0.008
Buprenorphine 135 (0.9) 21 (15.6) 1.36 0.85–2.18 0.20 1.25 0.78–2.01 0.35
Cathinonesa 148 (1.0) 17 (11.5) 0.96 0.58–1.59 0.86 1.19 0.71–1.99 0.51
Z-drugs 94 (0.6) 13 (13.8) 1.19 0.66–2.13 0.57 1.19 0.65–2.15 0.58
Ketamine 284 (1.9) 33 (11.6) 0.97 0.67–1.40 0.87 1.14 0.79–1.66 0.48
Benzodiazepines 2377 (15.7) 346 (14.6) 1.32 1.16–1.50 < 0.001 1.13 0.99–1.30 0.065
MDMA 1189 (7.9) 132 (11.1) 0.92 0.76–1.10 0.35 1.00 0.82–1.22 0.99
Ethanolb 6246 (41.3) 683 (10.9) 0.85 0.77–0.94 0.001 0.94 0.84–1.05 0.25
Amphetamine 1991 (13.2) 241 (12.1) 1.02 0.88–1.18 0.81 0.92 0.79–1.07 0.28
Opioidsc 752 (5.0) 84 (11.2) 0.92 0.73–1.17 0.51 0.88 0.69–1.13 0.32
Methadone 436 (2.9) 48 (11.0) 0.91 0.67–1.23 0.54 0.82 0.61–1.12 0.22
NPSd 116 (0.8) 11 (9.5) 0.77 0.41–1.44 0.41 0.81 0.43–1.53 0.52
Cocaine 2440 (16.1) 243 (10.0) 0.79 0.68–0.91 0.001 0.80 0.68–0.93 0.004
Cannabis 2362 (15.6) 233 (9.9) 0.78 0.67–0.90 0.001 0.79 0.67–0.92 0.003
LSD 198 (1.3) 18 (9.1) 0.74 0.45–1.20 0.22 0.77 0.47–1.25 0.29
GHB 2764 (18.3) 246 (8.9) 0.68 0.59–0.78 < 0.001 0.76 0.64–0.89 0.001
Crack 373 (2.5) 38 (10.2) 0.83 0.59–1.17 0.29 0.66 0.47–0.93 0.019
Methamphetamine 861 (5.7) 61 (7.1) 0.55 0.42–0.71 < 0.001 0.65 0.49–0.85 0.002
Pregabalin 99 (0.7) 7 (7.1) 0.56 0.26–1.21 0.14 0.48 0.22–1.04 0.064
Mephedrone 404 (2.7) 17 (4.2) 0.32 0.20–0.52 < 0.001 0.41 0.25–0.67 < 0.001
Other 700 (4.6) 66 (9.4) 0.76 0.59–0.98 0.036 0.82 0.63–1.07 0.14
Unknown 898 (5.9) 105 (11.7) 0.98 0.79–1.20 0.81 0.94 0.75–1.18 0.56
Total 15,135 (100) 1807 (11.9)

Logistic regression analysis. Numbers and percentages in the columns add up to more than the totals, as more than one toxic agent was taken in 9796/15135 (64.7%) cases

All drugs were included in the multivariate analysis. Reference groups are cases not involving the specified drug

Odds ratios are adjusted for the variables in the table. Adjusted odds ratios for associations with p < 0.05 are given in bold types

CI Confidence interval, GHB Gammahydroxybutyrate, LSD Lysergic acid diethylamide, MDMA Methylenedioxymethamphetamine, NPS Novel psychoactive substances, OR Odds ratio

aCathinones other than mephedrone

bIsolated alcohol intoxications not included

cUnspecified opioids and opioids other than heroin, methadone, and buprenorphine

dUnspecified NPS and NPS other than cathinones and synthetic cannabinoids